[Prenatal treatment of congenital toxoplasmosis].
Chemla
C
C
Villena
I
I
Trenque
T
T
Pinon
J-M
JM
D000962:Antimalarials / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D002955:Leucovorin / Q000627:therapeutic use; D009503:Neutropenia / Q000139:chemically induced; D011247:Pregnancy; D011295:Prenatal Care; D011739:Pyrimethamine / Q000627:therapeutic use*; D013413:Sulfadoxine / Q000627:therapeutic use*; D014125:Toxoplasmosis, Congenital / Q000188:drug therapy*; D014803:Vitamin B Complex / Q000627:therapeutic use
D000962:Antimalarials; D004338:Drug Combinations; D014803:Vitamin B Complex; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D002955:Leucovorin; D011739:Pyrimethamine